Icon ICLR
NASDAQ ICLR
$203.77 -1.37 (-0.67%)
At close: Nov 3, 2026 · 4:00 PM EST

Icon (ICLR) EBITDA Margin (2009 - 2026)

Updated

Icon's EBITDA Margin came in at 14.73% for the quarter ended Sep 30, 2026, up 20.60 percentage points from -5.87% a year earlier and up 3.58 percentage points from the prior quarter.

Analysis

Icon (ICLR) EBITDA Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Icon reported EBITDA Margin of 13.28%, up 2.62 percentage points year-over-year; for the year ended Dec 31, 2025, it was 14.08%, down 10.16 percentage points from the prior year.

  • EBITDA Margin carries a five-year change of -2.98 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, EBITDA Margin was 24.24% in the year ended Dec 31, 2024 (-1.14 pp), 25.39% in the year ended Dec 31, 2023 (+0.83 pp), 24.56% in the year ended Dec 31, 2022 (+6.50 pp) and 18.06% in the year ended Dec 31, 2021 (+1.00 pp).
  • The figure for the quarter ended Sep 30, 2026 represents the highest quarterly EBITDA Margin since the quarter ended Jun 30, 2025.
  • Year-over-year, EBITDA Margin increased in 1 of the last eight quarters, with an average year-over-year change of -2.95 percentage points.
  • The fastest year-over-year change in EBITDA Margin over five years came in the quarter ended Sep 30, 2026 (a gain of 20.60 percentage points), and the weakest in the quarter ended Sep 30, 2025 (a drop of 24.59 percentage points).
  • Business Quant data shows ICLR's EBITDA Margin at 11.15% (quarter ended Jun 30, 2026), 13.06% (quarter ended Mar 31, 2026) and 14.18% (quarter ended Dec 31, 2025) in the three quarters before the quarter ended Sep 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Iqvia Holdings 42.58 Bn 33.96 Bn 1.50 Bn 20.28%
2 Medpace Holdings 18.13 Bn 15.77 Bn 223.89 Mn 24.04%
3 Charles River Laboratories International 16.15 Bn 15.39 Bn 363.37 Mn 18.64%
4 Icon 15.71 Bn 12.48 Bn 491.83 Mn 14.73%
5 Fortrea Holdings 1.93 Bn 1.22 Bn 139.50 Mn 5.06%
6 Ginkgo Bioworks Holdings 627.55 Mn -134.53 Mn 18.44 Mn -229.38%
7 Evotec SE 540.45 Mn -1.07 Bn - -
8 Champions Oncology 68.48 Mn 44.13 Mn 7.70 Mn -0.62%
9 MindWalk Holdings 51.38 Mn 15.04 Mn 1.61 Mn -152.92%
10 Natural Alternatives International 6.45 Mn -21.63 Mn 1.73 Mn -34.75%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.73%
Jun 30, 2026 11.15%
Mar 31, 2026 13.06%
Dec 31, 2025 14.18%
Sep 30, 2025 -5.87%
Jun 30, 2025 16.19%
Mar 31, 2025 16.10%
Dec 31, 2024 16.92%
Sep 30, 2024 18.72%
Jun 30, 2024 18.69%
Mar 31, 2024 20.98%
Dec 31, 2023 18.38%
Sep 30, 2023 20.19%
Jun 30, 2023 17.72%
Mar 31, 2023 18.52%
Dec 31, 2022 17.83%
Sep 30, 2022 20.08%
Jun 30, 2022 16.81%
Mar 31, 2022 16.70%
Dec 31, 2021 15.52%
API Access

Icon EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ICLR&period=max&api_key=YOUR_API_KEY